News

Results from an international Phase III clinical trial presented at the 2025 ASCO Annual Meeting evaluate a treatment regimen combining encorafenib and cetuximab with mFOLFOX6 chemotherapy in patients with previously untreated BRAF V600E-mutant metastatic colorectal cancer (mCRC).

A large randomized trial has found that as-needed use of a fixed-dose combination of albuterol and budesonide significantly reduces the risk of severe asthma exacerbations compared to albuterol alone in patients with mild asthma.

A new study has identified key risk factors that may predispose individuals to long-term shedding (LTS) of non-typhoidal Salmonella (NTS), offering insights into why certain patients remain contagious weeks after initial infection.

Cognitive behavioral therapy (CBT) and mindfulness may offer sustained reductions in pain and disability for adults with non-specific chronic low back pain, according to a new systematic review and meta-analysis of 75 randomized controlled trials encompassing over 15,000 participants.

New research suggests that Mohs micrographic surgery (MMS) alone may lead to lower recurrence rates than when combined with photodynamic therapy (PDT) in treating locally advanced basal cell carcinoma (laBCC), particularly in non-aggressive subtypes.

A new deep-learning framework using MRI scans offers promising accuracy in predicting brain age, cognitive decline, and amyloid plaque buildup, key factors in the early detection of Alzheimer’s disease and related neurodegenerative disorders.

Adults hospitalized with respiratory syncytial virus (RSV) face a significantly greater risk of acute cardiovascular events compared to those admitted for COVID-19 or influenza, according to new findings from a population-based study.

Candida endophthalmitis and chorioretinitis, sight-threatening complications of candidemia, are on the rise and require faster, more coordinated care, according to a recent review.